Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 4, Issue 5 , Pages 361-367 , September 2008

Health service utilization among Alzheimer's disease patients: Evidence from managed care

  • Jennifer R. Frytak

      Affiliations

    • i3 Innovus, Eden Prairie, MN, USA
    • Corresponding Author InformationCorresponding author. Tel.: 952-833-8001; Fax: 952-833-6045.
    • ,
  • Henry J. Henk

      Affiliations

    • i3 Innovus, Eden Prairie, MN, USA
    • ,
  • Yang Zhao

      Affiliations

    • Eli Lilly and Company, Indianapolis, IN, USA
    • ,
  • Lee Bowman

      Affiliations

    • Eli Lilly and Company, Indianapolis, IN, USA
    • ,
  • Jennifer A. Flynn

      Affiliations

    • Eli Lilly and Company, Indianapolis, IN, USA
    • ,
  • Michael Nelson

      Affiliations

    • i3 Innovus, Eden Prairie, MN, USA

References 

  1. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003;60:1119–1122
  2. Ernst RL, Hay JW. The US economic and social costs of Alzheimer's disease revisited. Am J Public Health. 1994;84:1261–1264
  3. Ernst RL, Hay JW, Fenn C, Tinklenberg J, Yesavage JA. Cognitive function and the costs of Alzheimer's disease: an exploratory study. Arch Neurol. 1997;54:687–693
  4. Cummings JL. Alzheimer's disease. N Engl J Med. 2004;351:56–67
  5. Koppel R. Alzheimer's disease. the costs to U.S. businesses in 2002. Wyncote, PA: Social Research Corporation. Prepared for the Alzheimer's Association, 2002.
  6. Hill JW, Futterman R, Duttagupta S, Mastey V, Lloyd JR, Fillit H. Alzheimer's disease and related dementias increase costs of comorbidities in managed Medicare. Neurology. 2002;58:62–70
  7. Leon J, Cheng CK, Neumann PJ. Alzheimer's disease care: costs and potential savings. Health Aff. 1998;17:206–216
  8. Max W, Webber P, Fox P. Alzheimer's disease. the unpaid burden of caring. J Aging Health 1995;7179–99.
  9. Brummel-Smith K, Weiner M, Powe NR, Weller WE, Shaffer TJ, Anderson GF. Alzheimer's disease under managed care: implications from Medicare utilization and expenditure patterns. J Am Geriatr Soc. 1998;46:762–770
  10. Menzin J, Lang K, Friedman M, Neumann P, Cummings JL. The economic cost of Alzheimer's disease and related dementias to the California Medicaid Program (“Medi-Cal”) in 1995. Am J Geriatr Psychiatry. 1999;7:300–308
  11. Gutterman EM, Markowitz JS, Lewis B, Fillit H. Cost of Alzheimer's disease and related dementia in managed-Medicare. J Am Geriatr Soc. 1999;47:1065–1071
  12. Richards KM, Shepherd MD, Crismon ML, Snyder EH, Jermain DM. Medical services utilization and charge comparisons between elderly patients with and without Alzheimer's disease in a managed care organization. Clin Ther. 2000;22:775–791
  13. Martin BC, Ricci JF, Kotzan JA, Lang K, Menzen J. The net cost of Alzheimer's disease and related dementia: a population-based study of Georgia Medicaid recipients. Alzheimer Dis Assoc Disord. 2000;14:151–159
  14. Sloan FA, Taylor DH. Effect of Alzheimer's disease on the cost of treating other diseases. Alzheimer Dis Assoc Disord. 2002;16:137–143
  15. Fillit H, Hill JW, Futterman R. Health care utilization and costs of Alzheimer's disease: the role of comorbid conditions, disease stage, and pharmacotherapy. Fam Med. 2002;34:528–535
  16. McCormack LA, Gabel JR, Whitmore H. Trends in retiree health benefits. Health Aff. 2002;21:169–176
  17. Newcomer R, Clay T, Luxenberg JS, Miller RH. Misclassification and selection bias when identifying Alzheimer's disease solely from Medicare claims records. J Am Geriatr Soc. 1999;47:215–219
  18. Leibson C, Owens T, O'Brien P, Waring S, Tangalos E, Hanson V, et al. Use of physician and acute care services by persons with and without Alzheimer's disease: a population-based comparison. J Am Geriatr Soc. 1999;47:864–869
  19. Blough DK, Madden CW, Hornbrook MC. Modeling risk using generalized linear models. J Health Econ. 1999;18:153–171
  20. Manning WG. The logged dependent variable, heteroscedasticity, and the retransformation problem. J Health Econ. 1998;17:283–295
  21. Efron B, Tibshirani R. An introduction to the bootstrap. New York: Chapman & Hall; 1993;
  22. Manning WG, Fryback DG, Weinstein MC. Reflecting uncertainty in cost-effectiveness analysis. In:  Gold MR,  Siegel JE,  Russell LB,  Weinstein MC editor. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996;p. 247–275

PII: S1552-5260(08)00079-4

doi: 10.1016/j.jalz.2008.02.007

Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 4, Issue 5 , Pages 361-367 , September 2008

Article Tools